Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

A novel strategy for clustering major depression individuals using whole-genome sequencing variant data.

Yu C, Baune BT, Licinio J, Wong ML.

Sci Rep. 2017 Mar 13;7:44389. doi: 10.1038/srep44389.

2.

Functional Polymorphism in the Interleukin 6 (IL6) Gene with Respect to Depression Induced in the Course of Interferon-α and Ribavirin Treatment in Chronic Hepatitis Patients.

Frydecka D, Pawłowski T, Pawlak D, Małyszczak K.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):169-175. doi: 10.1007/s00005-016-0441-7.

3.

Genetic Analysis of BDNF, GNB3, MTHFR, ACE and APOE Variants in Major and Recurrent Depressive Disorders in Russia.

Bondarenko EA, Shadrina MI, Grishkina MN, Druzhkova TA, Akzhigitov RG, Gulyaeva NV, Guekht AB, Slominsky PA.

Int J Med Sci. 2016 Dec 8;13(12):977-983.

4.

Association of ATP6V1B2 rs1106634 with lifetime risk of depression and hippocampal neurocognitive deficits: possible novel mechanisms in the etiopathology of depression.

Gonda X, Eszlari N, Anderson IM, Deakin JF, Bagdy G, Juhasz G.

Transl Psychiatry. 2016 Nov 8;6(11):e945. doi: 10.1038/tp.2016.221.

5.

The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population.

Otowa T, Kawamura Y, Tsutsumi A, Kawakami N, Kan C, Shimada T, Umekage T, Kasai K, Tokunaga K, Sasaki T.

PLoS One. 2016 Aug 16;11(8):e0160823. doi: 10.1371/journal.pone.0160823.

6.

Association between reduced white matter integrity in the corpus callosum and serotonin transporter gene DNA methylation in medication-naive patients with major depressive disorder.

Won E, Choi S, Kang J, Kim A, Han KM, Chang HS, Tae WS, Son KR, Joe SH, Lee MS, Ham BJ.

Transl Psychiatry. 2016 Aug 9;6(8):e866. doi: 10.1038/tp.2016.137.

7.

CT genotype of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is protector factor of major depressive disorder in the Tunisian population: a case control study.

Sayadi MA, Achour O, Ezzaher A, Hellara I, Omezzine A, Douki W, Bousslama A, Gaha L, Najjar MF.

Ann Gen Psychiatry. 2016 Jul 30;15:18. doi: 10.1186/s12991-016-0103-5.

8.

Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.

Noordam R, Avery CL, Visser LE, Stricker BH.

Pharmacogenomics. 2016 Jun;17(9):1029-40. doi: 10.2217/pgs-2016-0024.

PMID:
27248517
9.

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Young JJ, Silber T, Bruno D, Galatzer-Levy IR, Pomara N, Marmar CR.

Front Psychiatry. 2016 Apr 25;7:72. doi: 10.3389/fpsyt.2016.00072. Review.

10.

Utilizing yeast chemogenomic profiles for the prediction of pharmacogenomic associations in humans.

Silberberg Y, Kupiec M, Sharan R.

Sci Rep. 2016 Mar 30;6:23703. doi: 10.1038/srep23703.

11.

Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia.

Burke SL, Maramaldi P, Cadet T, Kukull W.

Int Psychogeriatr. 2016 Sep;28(9):1409-24. doi: 10.1017/S1041610216000405.

PMID:
27020605
12.

Sports genetics: the PPARA gene and athletes' high ability in endurance sports. A systematic review and meta-analysis.

Lopez-Leon S, Tuvblad C, Forero DA.

Biol Sport. 2016 Mar;33(1):3-6. doi: 10.5604/20831862.1180170.

13.

Role of Hybrid Brain Imaging in Neuropsychiatric Disorders.

Burhan AM, Marlatt NM, Palaniyappan L, Anazodo UC, Prato FS.

Diagnostics (Basel). 2015 Dec 4;5(4):577-614. doi: 10.3390/diagnostics5040577. Review.

14.

Animal Models of Maternal Immune Activation in Depression Research.

Ronovsky M, Berger S, Molz B, Berger A, Pollak DD.

Curr Neuropharmacol. 2016;14(7):688-704. Review.

PMID:
26666733
15.

The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?

Jeon WJ, Dean B, Scarr E, Gibbons A.

Curr Neuropharmacol. 2015;13(6):739-49. Review.

16.

No Association of BDNF, COMT, MAOA, SLC6A3, and SLC6A4 Genes and Depressive Symptoms in a Sample of Healthy Colombian Subjects.

González-Giraldo Y, Camargo A, López-León S, Forero DA.

Depress Res Treat. 2015;2015:145483. doi: 10.1155/2015/145483.

17.

Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression.

Ching-López A, Cervilla J, Rivera M, Molina E, McKenney K, Ruiz-Perez I, Rodríguez-Barranco M, Gutiérrez B.

Neuropsychiatr Dis Treat. 2015 Oct 22;11:2743-54. doi: 10.2147/NDT.S90369.

18.

In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women--A GWAS Study Using the iCOGS Custom Genotyping Array.

Schoormans D, Darabi H, Li J, Brandberg Y, Eriksson M, Zwinderman KH, Sprangers MA, Hall P.

PLoS One. 2015 Oct 15;10(10):e0140563. doi: 10.1371/journal.pone.0140563.

19.

The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders.

Smoller JW.

Neuropsychopharmacology. 2016 Jan;41(1):297-319. doi: 10.1038/npp.2015.266. Review.

20.

BDNF promoter methylation and genetic variation in late-life depression.

Januar V, Ancelin ML, Ritchie K, Saffery R, Ryan J.

Transl Psychiatry. 2015 Aug 18;5:e619. doi: 10.1038/tp.2015.114.

Supplemental Content

Support Center